To amend the Federal Food, Drug, and Cosmetic Act to include a safe harbor for communication of information with respect to a vaccine authorized for emergency use under such Act that is provided or distributed to a health care provider, and for other purposes.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 4, 2021)
This bill prohibits using certain communications to establish that a vaccine authorized for emergency use violates specified laws relating to drug safety, such as laws concerning drug misbranding and the authorization of new drugs.
Specifically, the bill applies to certain communications about the use of such a vaccine that has been provided to certain health care entities. Such a communication must be (1) neither false nor misleading when measured objectively against the available information at the time; (2) accompanied by certain disclaimers, if required, including a statement identifying any differences between the communicated information and the vaccine's authorized labeling; and (3) based on competent and reliable scientific evidence.
What just happenedJun 7, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJun 4, 2021
- Jun 7, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 4, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jun 4, 2021IntroReferralIntro-H
Introduced in House
- Jun 4, 2021IntroReferral1000
Introduced in House